Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SEngine Precision Medicine
Seattle/Bothell, Washington, United Statessenginemedicine.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Commercial
01
Overview
SEngine’s PARIS® Test has been commercialized as a CLIA-certified diagnostic that provides personalized drug sensitivity reports for solid tumor patients. The company leverages its data and technology for preclinical drug discovery collaborations with pharma/biotech partners. Clinical results indicate the test can identify effective treatments beyond what DNA sequencing alone predicts (~15% vs up to ~80% actionable options identified by PARIS® Test), but no late-stage clinical trial outcomes or approved therapeutics have been reported yet.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeProteolysis-targeting chimera therapy (PROTAC)Diagnostic test (PARIS® Test)Cell-based assay (patient-derived organoids)
- Industry
- Biotech
02
Partnerships
Strategic collaborations with biopharmaceutical/pharma companies leveraging their precision oncology platform for drug discovery
Beyond the preview
Go deeper on SEngine Precision Medicine.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SEngine Precision Medicine.